Clinical Data Management Systems Market worth USD 5.4 billion by 2030, says Global Market Insights Inc.

Prominent players operating in the Clinical Data Management Systems (CDMS) industry are Oracle Corporation, eClinical Solution LLC, IBM Corporation, CIMS, Axiom Real-Time Metrics, Medidata Solution (Dassault Systemes)., Fortress Medical, Veeva Systems, OpenClinica LLC, and Ennov.

SELBYVILLE, Del., July 7, 2022 /PRNewswire/ — The clinical data management systems market value is projected to reach USD 5.4 billion by 2030 according to a new research report by Global Market Insights Inc.

Clinical Data Management Systems (CDMS) Market

Pharmaceutical and biopharmaceutical industry has one of the highest R&D expenses worldwide. Therefore, this will encourage various biopharma & pharma companies to outsource clinical trials services, thereby increasing the adoption rate. Furthermore, the clinical trials that companies opt to outsource include extensive research and tasks. Thus, to manage overall process of clinical trials, various companies opt for software solution including clinical data management solution to manage the large volume data, thereby augmenting the market expansion.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3131

Licensed enterprise solution segment surpassed USD 207.1 million in 2021. The licensed enterprise based CDMS also known as on demand CDMS are designed by a third party or a company to be licensed or sold to pharmaceutical and biotech firms. Licensed enterprise software is created considering all regulatory guidelines and are validated. Some CDMS tools like Oracle Clinical and Clintrial are of industry standards. These systems are not compatible for new component/module addition. However, these are preferred choice by industry players due to standardization, testing against set modules and validation.

Some major findings of the clinical data management systems market report include:

  • Growing R&D expenditure and increasing number of drugs in various phases is anticipated to fuel the adoption of CTMS solution.
  • The necessity to fasten the medical device and diagnostic trials is boosting the business landscape.
  • The upsurge in regional trials and emergence of severe diseases are key factors driving the Asia Pacific market revenue.
  • Industry players are focusing on various strategies such as acquisition, business expansion and novel service launches to consolidate their market presence.

Browse key industry insights spread across 115 pages with 113 market data tables & 14 figures & charts from the report, “Clinical Data Management Systems Market Analysis By Delivery Mode (Licensed Enterprise Solutions, Cloud-based Solutions, Web-hosted Solutions), End-use (Contract Research Organizations, Medical Device Companies, Pharma/Biotech Companies), Industry Analysis Report, Regional Outlook , Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/clinical-data-management-systems-market

Clinical data management systems market from medical device companies segment accounted for 16.1% revenue proportion in 2021 and is projected to witness considerable CAGR during the forecast timeframe. The medical device companies are in continuously inventions of novel medical devices and diagnostic tools for which they keep conducting medical device and diagnostic trials. The CDMS enables to manage data for the entire device and diagnostic development lifecycle. It helps reduce study time and conduct cost effective study with real time data reporting. Also, it can be useful to conduct multicentered studies and capture data from various sources.

Asia-Pacific clinical data management systems market is estimated to show robust CAGR of 13.8% during the forecast period. With need for effective clinical data and process management tools, the market will foresee immense growth opportunities in Asia Pacific region. Huge patient population, emergence of severe diseases, increasing clinical trials and R&D are some of regional growth driving factors. Also, there are several observational and post marketing surveillance studies going on continuously in the region especially Southeast Asian countries which is expected to boost the demand for such software.

A few notable companies operating in the clinical data management systems market include Oracle Corporation, eClinical Solution LLC, IBM Corporation, CIMS, Axiom Real-Time Metrics, Medidata Solution (Dassault Systemes)., Fortress Medical, Veeva Systems, OpenClinica LLC, Ennov, among others.

Request for customization of this research report @ https://www.gminsights.com/roc/3131

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: [email protected] 

Global Market Insights Inc. Logo

Photo: https://mma.prnewswire.com/media/1855079/CDMS_Market.jpg
Logo: https://mma.prnewswire.com/media/661916/GMI.jpg 

Clinical Data Management Systems Market worth USD 5.4 billion by 2030, says Global Market Insights Inc. WeeklyReviewer

PR Newswire Science News

World Reviewer Staff
World Reviewer Staffhttps://weeklyreviewer.com/
The first logical thought has to be "no way". I'm the World Observer! Ill find and share important news all day.

Latest articles

Earnings Disclosure

WeeklyReviewer earns primarily through affiliates and ads. We don’t encourage anyone to click on ads for any other purpose but your own. We recommend products and services often for our readers, and through many we will earn commissions through affiliate programs.

Related articles